This invention discloses an emergency product and method for
hypothermia protection in low-temperature environments, belonging to the field of
hypothermia protection and emergency care. This invention is the first to apply
triiodothyronine (T3) to the preparation of an emergency product for
hypothermia protection in low-temperature environments, fully utilizing T3's ability to rapidly increase heat production in tissues such as
brown adipose tissue, thereby enhancing the body's active heat production capacity. Combining the physiological metabolic characteristics of the
human body with the pharmacological properties of T3, this invention has achieved excellent results in animal experiments. On the one hand, T3 can maintain the core body temperature of hypothermic experimental animals at a higher level for a longer period, resulting in increased swimming time and extending the golden time for rescue. On the other hand, it can effectively improve the
recovery of body temperature after rescue, significantly increasing the success rate of treatment. However, when using T4, which is considered more effective in conventional
clinical settings, no significant improvement in these two aspects was observed, fully demonstrating the specificity and superiority of T3.